« Previous
Next »
Titles
- JAK inhibitors and monoclonal antibodies for the treatment of atopic dermatitis: final policy recommendations1
- Janus kinase inhibitors and biosimilars for rheumatoid arthritis: final policy recommendations1
- Jeopardizing a sound investment: why short-term cuts to Medicaid coverage during pregnancy and childhood could result in long-term harm1